License the latest technology from Imperial College London
Technology available for licensing
Imperial College London is among the world’s leading research universities, and one of the few focused exclusively on Science, Technology, Engineering, Medicine and Business. Technology developed by Imperial’s world-leading researchers is protected and packaged by our expert commercialisation specialists.
Available technologies span all areas of research undertaken at Imperial. If your business is considering licensing technology, you can view available technologies and enquire directly through this site.
Browse technologies and innovations derived from research undertaken by academics at Imperial College London
Wearable enabling visually impaired user to hear echoes bounced back from structures and objects, allowing the user to perceive their spatial environment
Neurosurgical clip and actuator with stability and freedom of movement; non-invasive tumour identification probe for real-time mapping
Topical use of Capsaicin or TRPV 1 agonists for the prevention of diabetic ulcers in a patient suffering from diabetic peripheral neuropathy (DPN).
A binder-less, fully dry, room temperature electrode manufacturing technology — a sustainable, cost-effective, and efficient alternative.
A system designed for generating ultrafast mid-infrared laser pulses at the wavelength at which water molecules absorb light resonantly
A green chemistry solution to give discarded fabric a second chance, salvaging their dyes through dye recycling
Two patent-pending technologies for the creation of sustainably produced lignin-based carbon fibres
The Nanograb technology empowers scientists and doctors to selectively detect biomarkers by creating super-selective systems made out of DNA.
Carbon neutral cement aimed at increasing production of carbon neutral or negative concrete and decarbonisation of construction
A nutritional analytics platform harnessing networked AI and omics data to identify how dietary biomolecules and phytochemically rich “Hyperfoods” can help to prevent or fight diseases such as cancer or COVID-19
Licensing and IP performance 2019/20
Imperial inventors submitted 250 invention disclosures to our IPC team during the year
Imperial College London's licensing portfolio comprises 244 licences
Imperial filed 137 patents (including PCT applications) during the year
Imperial's patent portfolio reached 331 patents during the year
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
The UK Cystic Fibrosis Gene Therapy Consortium (GTC) is one of the partners in a licensing agreement with Boehringer Ingelheim. Find out more
Imperial has licensed iNKT cell technology based on research by Prof. Tassos Karadimitris to SUDA Pharmaceuticals. Find out more
Imperial will benefit from continued support for translational biomedical research under a unique technology transfer model. Find out more
Sign up for updates
Sign up for monthly technology alerts via email, and find other ways to connect with us.